share_log

HOOKIPA Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Invus Public Equities, L.P.(5.9%),Invus Public Equities Advisors, LLC(5.9%), etc.

SEC ·  Jul 9 06:53
Summary by Futu AI
On June 1, 2023, a Schedule 13G was filed with the United States Securities and Exchange Commission by several entities and an individual, indicating a change in ownership of shares in HOOKIPA Pharma Inc. The filing revealed that Invus Public Equities, L.P., along with its advisors and related entities, including Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, and Mr. Amaury Wittouck, collectively hold 5,666,410 shares of common stock in HOOKIPA Pharma. This represents 5.9% of the company's class as of the filing date. Previously, on June 1, 2023, the percentage of class owned was reported as 7.3%. The shares are reported to be held with sole voting and dispositive power by each reporting person, with no shared power reported. The filing includes a certification that the shares were not acquired for the purpose of changing or influencing the control of HOOKIPA Pharma Inc. and were not held in connection with any transaction having such purpose or effect.
On June 1, 2023, a Schedule 13G was filed with the United States Securities and Exchange Commission by several entities and an individual, indicating a change in ownership of shares in HOOKIPA Pharma Inc. The filing revealed that Invus Public Equities, L.P., along with its advisors and related entities, including Artal International S.C.A., Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend, and Mr. Amaury Wittouck, collectively hold 5,666,410 shares of common stock in HOOKIPA Pharma. This represents 5.9% of the company's class as of the filing date. Previously, on June 1, 2023, the percentage of class owned was reported as 7.3%. The shares are reported to be held with sole voting and dispositive power by each reporting person, with no shared power reported. The filing includes a certification that the shares were not acquired for the purpose of changing or influencing the control of HOOKIPA Pharma Inc. and were not held in connection with any transaction having such purpose or effect.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.